Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.42 EUR | 0.00% | +0.46% | -0.84% |
Jun. 11 | Recordati buys back more than 50,000 of its own ordinary shares | AN |
Jun. 04 | Recordati continues buyback plan; nearly 64,000 shares purchased | AN |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.84% | 10.94B | A- | ||
+48.53% | 779B | C+ | ||
+40.67% | 631B | B | ||
-6.37% | 354B | C+ | ||
+20.93% | 333B | B- | ||
+8.21% | 301B | C+ | ||
+16.75% | 249B | B+ | ||
-1.19% | 216B | A+ | ||
+10.85% | 214B | B- | ||
+4.40% | 163B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- REC Stock
- Ratings Recordati